YGION Biomedical’s CSO, Dr Anna-Dorothea Gorki is attending the 8th International Neoantigen Summit on June 24-26, in Amsterdam, Netherlands.
This conference brings together the global neoantigen community to address key challenges in the discovery, translation and clinical development of safe and cost-effective neoantigen therapies and vaccines to attract investors and ultimately improve the health of patients.
